HealthPartners Cancer Research Center

Saint Louis Park, Minnesota 55426

1 studies enrolling now · 4 studies all time

What they study most

Colorectal Cancer Metastatic, Gastric Cancer, Head and Neck Cancer, Malignant Neoplasm of Breast, Melanoma, Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable, Renal Cell Carcinoma, Resectable Non-Small-Cell Lung Cancer, Solid Tumor

Studies at this site

• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — Recruiting now
• Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer — Recruiting now
• Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib — Completed
• Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA) — Completed